Raymond James Initiates Strong Buy on Edgewise Therapeutics (EWTX) with $46 PT, Cites EDG-7500 Potential for HCM
Edgewise Therapeutics Inc. (NASDAQ:EWTX) is one of the biotech stocks to buy according to Wall Street analysts.
Edgewise Therapeutics Inc. (EWTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 15,518,492 | $203,447,430 | +4% | 5.08% |
| 2. | RA Capital Management Peter Kolchinsky | 9,902,633 | $129,823,519 | +12% | 2.19% |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 7,305,940 | $95,780,873 | +19% | 0.93% |
| 4. | Braidwell LP Alex Karnal | 5,210,831 | $68,313,994 | +112% | 2.34% |
| 5. | Perceptive Advisors Joseph Edelman | 4,639,949 | $60,829,731 | -30% | 2.26% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.13 | 124,193 | $2,500,005.09 | 443,792 | 2025-04-03 | Filing | |
| $20.13 | 372,578 | $7,499,995.14 | 14,809,075 | 2025-04-03 | Filing | |
| $20.13 | 124,193 | $2,500,005.09 | 443,792 | 2025-04-03 | Filing | |
| $20.13 | 372,578 | $7,499,995.14 | 14,809,075 | 2025-04-03 | Filing | |
| $11.00 | 454,545 | $4,999,995.00 | 14,436,497 | 2024-01-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.39 | 2,098 | $28,097.26 | 10,214 | 2025-08-12 | Filing | |
| $13.39 | 2,491 | $33,360.47 | 23,645 | 2025-08-12 | Filing | |
| $13.39 | 1,428 | $19,124.35 | 86,162 | 2025-08-12 | Filing | |
| $13.39 | 1,907 | $25,539.31 | 23,400 | 2025-08-12 | Filing | |
| $13.39 | 7,972 | $106,764.21 | 30,615 | 2025-08-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,781,046 | $88,899,513 | 0% | |
| 2. | 6,142,344 | $80,526,130 | 3.44% | |
| 3. | 5,503,349 | $72,134,463 | 0.04% | |
| 4. | 5,350,000 | $70,138,500 | 4.95% | |
| 5. | 4,841,500 | $63,472,065 | 0% |
News See All
10 Biotech Stocks to Buy According to Wall Street Analysts
On July 8, Jared Holz, Mizuho, joined 'Closing Bell Overtime' on CNBC to discuss if the biotech sector is ready for a breakout.
Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment
Edgewise Therapeutics Inc. (NASDAQ:EWTX) is one of the best up and coming stocks to invest in now.
13 Best Up and Coming Stocks to Invest In Now
Earlier on June 11, Jeff Richards of Notable Capital joined 'Closing Bell' on CNBC to express optimism about the upcoming activity in the IPO market.
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential
On April 24, Jill Carey Hall, BofA Securities head of U.S. small/mid-cap strategy, appeared on 'Closing Bell' to talk about the impact of tariffs on small caps.
11 Most Promising Small-Cap Stocks According to Analysts
Robert Teeter of Silvercrest Asset Management recently appeared in an interview to express that he thinks small-cap stocks are currently facing a choppy market, but he also acknowledged that he anticipates...
10 Unstoppable Stocks That Could Double Your Money
Generating significant returns and multiplying their money in the stock market remains a primary goal for most investors.
Should You Invest in Edgewise Therapeutics (EWTX)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
10 Best Hot Stocks To Buy Right Now
While the market is seeing significant positives after the Fed rate cut, there have been some pressures.